<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.malariajournal.com/feeds/articlecomments?arxId=1475-2875-8-313&amp;format=rss&amp;version=&amp;quantity=">
        <title>Article Comments - 'Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy

'</title>
        <link>http://www.malariajournal.com/content/8/1/313/comments</link>
        <description>The latest comments on the article 'Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy

'</description>
        <dc:date>2010-01-01T23:46:16Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li resource="http://www.malariajournal.com/content/8/1/313" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.malariajournal.com/content/8/1/313/comments#387665">
        <title>prescription practices and national antimalarial treatment guideline</title>
        <link>http://www.malariajournal.com/content/8/1/313/comments#387665</link>
        <description>&lt;p&gt;A research of great interest considering the enormity of the problem of resistance to antimalarials. I just wish to add that we need to find out how many prescribers are aware or have access to the national antimalarial treatment guideline and how many make use of it especially against the background that prescriptions for malaria are generated by varied healthcare providers since most antimalarials in Nigeria are available over-the-counter.&lt;/p&gt;</description>
                <dc:creator>folasade lawal</dc:creator>
                <dc:date>2010-01-01T23:46:16Z</dc:date>
        <prism:references>http://www.malariajournal.com/content/8/1/313</prism:references>
        <prism:person>Gbotosho et al.</prism:person>
        <prism:publicationName>Malaria Journal</prism:publicationName>
        <prism:volume>8</prism:volume>
        <prism:startingPage>313</prism:startingPage>
        <prism:publicationDate>Wed Dec 30 15:50:36 GMT 2009</prism:publicationDate>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

